Publications by authors named "Claudio Botti"

Claim this Profile
P
Preoperative Magnetic Seed Versus Wire-Guided Localization in the Treatment of Nonpalpable Breast Cancer: A Retrospective Observational Study at a Tertiary Care Center.
Amedeo Villanucci, Francesca Romana Ferranti, Sonia Cappelli, Flavia Cavicchi, Franco Graziano, Claudio Botti

Int J Breast Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six-Year Results From a Prospective Phase 2 Trial of 10-Fraction Hypofractionated Radiation Therapy in Locally Advanced Breast Cancer.
Paola Pinnarò, Silvia Takanen, Laura Marucci, Valeria Landoni, Antonella Soriani, Claudio Botti

Pract Radiat Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal deep learning for predicting neoadjuvant treatment outcomes in breast cancer: a systematic review.
Eriseld Krasniqi, Lorena Filomeno, Teresa Arcuri, Gianluigi Ferretti, Simona Gasparro, Claudio Botti

Biol Direct· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CircPVT1 weakens miR-33a-5p unleashing the c-MYC/GLS1 metabolic axis in breast cancer.
Alina Catalina Palcau, Claudio Pulito, Valentina De Pascale, Luca Casadei, Mariacristina Valerio, Claudio Botti

J Exp Clin Cancer Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study.
Eriseld Krasniqi, Lorena Filomeno, Teresa Arcuri, Francesca Sofia Di Lisa, Antonio Astone, Andrea Botticelli, Claudio Botti

Cancers (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast and cervical cancer in transgender men: literature review and a case report.
Francesca Sofia Di Lisa, Alice Villa, Lorena Filomeno, Teresa Arcuri, Benito Chiofalo, Claudio Botti

Ther Adv Med Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Indocyanine Green with conventional tracers for sentinel lymph node biopsy in breast cancer: A multidisciplinary evaluation of clinical effectiveness, safety, organizational and economic impact.
Maria Pinelli, Chiara Gerardi, Emanuele Lettieri, Madalina Maioru, Laura Marone, Claudio Botti

PLoS One· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 mutation as an emerging target in advanced breast cancer.
Giulia Bon, Francesca Sofia Di Lisa, Lorena Filomeno, Teresa Arcuri, Eriseld Krasniqi, Claudio Botti

Cancer Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA Damage Response in Early Breast Cancer: A Phase III Cohort in the Phobos Study.
Eriseld Krasniqi, Cristiana Ercolani, Anna Di Benedetto, Francesca Sofia Di Lisa, Lorena Filomeno, Claudio Botti

Cancers (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bcl-2 dependent modulation of Hippo pathway in cancer cells.
Simona D'Aguanno, Matteo Brignone, Stefano Scalera, Martina Chiacchiarini, Marta Di Martile, Claudio Botti

Cell Commun Signal· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regina Elena Institute (R.E.I.) Protocol for Breast Implant Salvage: Preliminary Results.
Giovanni Zoccali, Marcello Pozzi, Pierpaolo Gullo, Veronica Vietti Michelina, Claudio Botti

Clin Breast Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting Long Non-Coding RNAs and Circular RNAs as Pharmacological Targets in Triple-Negative Breast Cancer Treatment.
Alina Catalina Palcau, Renata Brandi, Nikolay Hristov Mehterov, Claudio Botti, Giovanni Blandino

Cancers (Basel)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sexual dysfunctions in breast cancer patients: evidence in context.
Riccardo Vizza, Elisabetta Maria Capomolla, Livia Tosetto, Giacomo Corrado, Valentina Bruno, Claudio Botti

Sex Med Rev· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from , a multicentric, observational study.
Francesca Sofia Di Lisa, Eriseld Krasniqi, Laura Pizzuti, Maddalena Barba, Katia Cannita, Andrea Botticelli, Claudio Botti

Front Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reverse strategy to locally advanced breast implant-associated anaplastic large cell lymphoma: A case report.
Sonia Cappelli, Francesco Marchesi, Marco Clementi, Letizia Perracchio, Francesca Palombi, Claudio Botti

Front Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study.
Eriseld Krasniqi, Francesca Sofia Di Lisa, Anna Di Benedetto, Maddalena Barba, Laura Pizzuti, Claudio Botti, Andrea Botticelli

Cancers (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic partial breast irradiation in primary breast cancer: A comprehensive review of the current status and future directions.
Silvia Takanen, Paola Pinnarò, Ilaria Farina, Francesca Sperati, Claudio Botti

Front Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical site infections in patients undergoing breast oncological surgery during the lockdown: An unexpected lesson from the COVID-19 pandemic.
Sonia Cappelli, Diletta Corallino, Marco Clementi, Stefano Guadagni, Fabio Pelle, Claudio Botti

G Chir· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions.
Sara Donzelli, Mario Cioce, Andrea Sacconi, Francesca Zanconato, Theodora Daralioti, Claudio Botti

Mol Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Dual-Energy Contrast-Enhanced Spectral Mammography Can Provide Useful Clinical Information About Prognostic Factors in Breast Cancer Patients: A Systematic Review of Literature.
Federica Vasselli, Alessandra Fabi, Francesca Romana Ferranti, Maddalena Barba, Claudio Botti

Front Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer metastasis: Is it a matter of OMICS and proper ex-vivo models?
Mario Cioce, Andrea Sacconi, Sara Donzelli, Claudia Bonomo, Letizia Perracchio, Claudio Botti

Comput Struct Biotechnol J· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Accuracy of Contrast-Enhanced, Spectral Mammography (CESM) and 3T Magnetic Resonance Compared to Full-Field Digital Mammography plus Ultrasound in Breast Lesions: Results of a (Pilot) Open-Label, Single-Centre Prospective Study.
Francesca Romana Ferranti, Federica Vasselli, Maddalena Barba, Francesca Sperati, Irene Terrenato, Claudio Botti

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial.
Eriseld Krasniqi, Laura Pizzuti, Maria Rosaria Valerio, Elisabetta Capomolla, Claudio Botti

Int J Med Sci· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting.
Laura Pizzuti, Eriseld Krasniqi, Isabella Sperduti, Maddalena Barba, Teresa Gamucci, Andrea Botticelli, Claudio Botti

Ther Adv Med Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Chemotherapy in Vulvar Cancers: Time to Rethink Standard of Care?
Marco Mazzotta, Laura Pizzuti, Eriseld Krasniqi, Francesca Sofia Di Lisa, Federico Cappuzzo, Claudio Botti, Andrea Botticelli

Cancers (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis